Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.094
+0.010 (0.92%)
Sep 2, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 372.85 million as of September 2, 2026. Its market cap has decreased by -4.87% in one year.
Market Cap
372.85M
Enterprise Value
246.08M
Revenue
18.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.09
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 372.85M, an increase of 334.58%. That is a compound annual growth rate of 16.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 372.85M | 18.40% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 739.19M |
| FluoGuide | 580.40M |
| Mendus AB | 487.41M |
| Xspray Pharma AB | 470.85M |
| Cantargia AB | 445.01M |
| Corline Biomedical AB | 422.05M |
| Sprint Bioscience AB | 348.20M |
| IRLAB Therapeutics AB | 262.33M |